Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer
Reece, Kelie M, Richardson, Emily D, Cook, Kristina M, Campbell, Tessa J, Pisle, Stephen T, Holly, Alesia J, Venzon, David J, Liewehr, David J, Chau, Cindy H, Price, Douglas K, Figg, William D
Published in Molecular cancer (28.04.2014)
Published in Molecular cancer (28.04.2014)
Get full text
Journal Article
Androgen receptor and HIF-1α interaction in prostate cancer
Reece, Kelie M, Troutman, Sarah M, Pressler, Heather M, Pisle, Stephen T, Figg, William Douglas
Published in Journal of clinical oncology (10.02.2012)
Published in Journal of clinical oncology (10.02.2012)
Get full text
Journal Article
Abstract 2331: Select epidithiodiketopiperazine (ETP) compounds disrupt the HIF-1α/p300 interaction and HIF-mediated transcription
Richardson, Emily D., Reece, Kelie M., Campbell, Tessa J., Pressler, Heather, Pisle, Stephen T., Figg, William D.
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article
Activity of oral VT-464, a selective CYP17-lyase inhibitor, in the LNCaP prostate cancer xenograft
Figg, William Douglas, Spencer, Shawn D., Pisle, Stephen T, Pressler, Heather M, Troutman, Sarah M, Eisner, Joel Robert, Rafferty, Stephen W, Schotzinger, Robert J, Moore, William R
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Abstract B28: Organic anion transporting polypeptide 1B3 as a novel biomarker for hypoxia in prostate cancer
Pressler, Heather M., Pisle, Stephen, Sissung, Tristan M., Cropp, Cheryl D., Price, Douglas K., Figg, William D.
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article
Abstract 3095: The molecular, cellular, and physiological consequences of disrupting the HIF-1α interaction
Reece, Kelie M., Pisle, Stephen T., Richardson, Emily D., Cook, Kristina M., Price, Douglas K., Figg, William D.
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Get full text
Journal Article
Activity of VT-464, a selective CYP17 lyase inhibitor, in the LNCaP prostate cancer xenograft model
Pisle, Stephen Todd, Pressler, Heather M, Troutman, Sarah M, Eisner, Joel Robert, Rafferty, Stephen W, Schotzinger, Robert J, Moore, William R, Figg, William Douglas
Published in Journal of clinical oncology (10.02.2012)
Published in Journal of clinical oncology (10.02.2012)
Get full text
Journal Article
Epidithiodiketopiperazines exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1[alpha]/p300 complex in a preclinical model of prostate cancer
Reece, Kelie M, Richardson, Emily D, Cook, Kristina M, Campbell, Tessa J, Pisle, Stephen T, Holly, Alesia J, Venzon, David J, Liewehr, David J, Chau, Cindy H, Price, Douglas K, Figg, William D
Published in Molecular cancer (28.04.2014)
Published in Molecular cancer (28.04.2014)
Get full text
Journal Article